These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7657663

  • 1. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB.
    J Biol Chem; 1995 Sep 01; 270(35):20794-800. PubMed ID: 7657663
    [Abstract] [Full Text] [Related]

  • 2. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J.
    J Biol Chem; 1995 Sep 08; 270(36):21158-66. PubMed ID: 7673148
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M, Rand MD, Mann KG.
    J Biol Chem; 1994 Dec 16; 269(50):31869-80. PubMed ID: 7989361
    [Abstract] [Full Text] [Related]

  • 4. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO, Kalafatis M, Mann KG.
    Protein Sci; 1997 Sep 16; 6(9):2016-27. PubMed ID: 9300501
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the molecular defect in factor VR506Q.
    Kalafatis M, Bertina RM, Rand MD, Mann KG.
    J Biol Chem; 1995 Feb 24; 270(8):4053-7. PubMed ID: 7876154
    [Abstract] [Full Text] [Related]

  • 6. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF, Kalafatis M, Shatos M, Mann KG.
    Arterioscler Thromb Vasc Biol; 1997 Nov 24; 17(11):2765-75. PubMed ID: 9409254
    [Abstract] [Full Text] [Related]

  • 7. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G.
    J Biol Chem; 1995 Nov 17; 270(46):27852-8. PubMed ID: 7499257
    [Abstract] [Full Text] [Related]

  • 8. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M, Haley PE, Lu D, Bertina RM, Long GL, Mann KG.
    Blood; 1996 Jun 01; 87(11):4695-707. PubMed ID: 8639839
    [Abstract] [Full Text] [Related]

  • 9. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB.
    Blood; 1998 Apr 15; 91(8):2818-29. PubMed ID: 9531592
    [Abstract] [Full Text] [Related]

  • 10. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
    Lu D, Kalafatis M, Mann KG, Long GL.
    Blood; 1994 Aug 01; 84(3):687-90. PubMed ID: 8043858
    [Abstract] [Full Text] [Related]

  • 11. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K, Dahlbäck B, Rosing J, Nicolaes GA.
    J Biol Chem; 2008 Aug 15; 283(33):22573-81. PubMed ID: 18519572
    [Abstract] [Full Text] [Related]

  • 12. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.
    Nicolaes GA, Sørensen KW, Friedrich U, Tans G, Rosing J, Autin L, Dahlbäck B, Villoutreix BO.
    Eur J Biochem; 2004 Jul 15; 271(13):2724-36. PubMed ID: 15206937
    [Abstract] [Full Text] [Related]

  • 13. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
    Norstrøm EA, Steen M, Tran S, Dahlbäck B.
    J Biol Chem; 2003 Jul 04; 278(27):24904-11. PubMed ID: 12707283
    [Abstract] [Full Text] [Related]

  • 14. Role of the membrane in the inactivation of factor Va by activated protein C.
    Kalafatis M, Mann KG.
    J Biol Chem; 1993 Dec 25; 268(36):27246-57. PubMed ID: 8262965
    [Abstract] [Full Text] [Related]

  • 15. Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.
    Barhoover MA, Kalafatis M.
    Blood Coagul Fibrinolysis; 2011 Jun 25; 22(4):317-24. PubMed ID: 21467919
    [Abstract] [Full Text] [Related]

  • 16. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
    Tran S, Dahlbäck B.
    J Thromb Haemost; 2010 Jan 25; 8(1):129-36. PubMed ID: 19874463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.
    Heeb MJ, Kojima Y, Greengard JS, Griffin JH.
    Blood; 1995 Jun 15; 85(12):3405-11. PubMed ID: 7780127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.